Uveitis and neurological diseases

British Journal of Ophthalmology

Volumn 88, Issue 12, 2004, Pages 1483-1484

  Gordon, Lynn K ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

DEMYELINATING DISEASE; DISEASE ASSOCIATION; EDITORIAL; HERPES VIRUS INFECTION; HUMAN; IMMUNOTHERAPY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PRIORITY JOURNAL; SYSTEMIC DISEASE; UVEITIS; VOGT KOYANAGI SYNDROME;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS;

EID: 9644291374     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2004.051797     Document Type: Editorial

References (11)

1. Dunn JP, Nozik RA. Uveitis: role of the physician in treating systemic causes. Geriatrics 1994;49:27-32.
2. Smith JR, Coster DJ. Diagnosing the systemic associations of anterior uveitis. Aust N Z J Ophthalmol 1998;26:319-26.
3. Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev 2003;2:119-25.
4. Rotrosen D, Matthews JB, Bluestone JA. The immune tolerance network: a new paradigm for developing tolerance-inducing therapies. J Allergy Clin Immunol 2002;110:17-23.
5. O'Neill DW, Adams S, Bhardwaj N. Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood 2004;(in press).
6. Schultes BC, Nicodemus CF. Using antibodies in tumour immunotherapy. Expert Opin Biol Ther 2004;4:1265-84.
7. Wiendl H, Hohlfeld R. Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials. BioDrugs 2002;16:183-200.
8. Nussenblatt RB. Bench to bedside: new approaches to the immunotherapy of uveitic disease. Int Rev Immunol 2002;21:273-89.
9. Greiner K, Murphy CC, Willermain F, et al. Anti-TNFalpha therapy modulates the phenotype of peripheral blood CD4+ T cells in patients with posterior segment intraocular inflammation. Invest Ophthalmol Vis Sci 2004;45:170-6.
10. Nussenblatt RB, Lane HC. Human immunodeficiency virus disease: changing patterns of intraocular inflammation. Am J Ophthalmol 1998;125:374-82.
11. Levinson RD, Vann R, Davis JL, et al. Chronic multifocal retinal infiltrates in patients infected with human immunodeficiency virus. Am J Ophthalmol 1998;125:312-24.